Vaccines, blood, antisera, toxins and cultures in Malaysia | The Observatory of Economic Complexity

About

Exports In 2022, Malaysia exported $11.7M in Vaccines, blood, antisera, toxins and cultures, making it the 70th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 609th most exported product in Malaysia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Malaysia are: Australia ($3.6M), Burma ($2.48M), Brunei ($1.51M), Singapore ($1.25M), and Switzerland ($816k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Malaysia between 2021 and 2022 were Australia ($2.64M), Burma ($2.25M), and Switzerland ($814k).

Imports In 2022, Malaysia imported $528M in Vaccines, blood, antisera, toxins and cultures, becoming the 55th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 99th most imported product in Malaysia. Malaysia imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($132M), Switzerland ($85.5M), Belgium ($60.7M), United States ($49.3M), and France ($42.6M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Malaysia between 2021 and 2022 were United Arab Emirates ($29M), Germany ($28.7M), and Thailand ($5.43M).

COMPANIES In 2023, leading companies such as Tesla (2) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Malaysia to the United States.

Latest Trends

June 2024

About

Overview In June 2024 Malaysia's Vaccines, blood, antisera, toxins and cultures exports accounted up to MYR2.18M and imports accounted up to MYR158M, resulting in a negative trade balance of MYR156M. Between June 2023 and June 2024 the exports of Malaysia's Vaccines, blood, antisera, toxins and cultures have increased by MYR434k (24.8%) from MYR1.75M to MYR2.18M, while imports decreased by MYR-26.7M (-14.4%) from MYR185M to MYR158M.

Destinations In June 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to Australia (MYR1.31M), Iran (MYR390k), Singapore (MYR325k), United States (MYR101k), and Vietnam (MYR32.4k), and were imported mostly from Germany (MYR45.1M), France (MYR32.8M), United States (MYR28.5M), Singapore (MYR12M), and Switzerland (MYR9.92M).

Growth In June 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Singapore (MYR236k or 53.4%). In June 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from Germany (MYR-160M or -90.1%), Thailand (MYR-73.1M or -99.9%), and Belgium (MYR-26.2M or -67.4%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (June 2023 - June 2024)MYR434k(24.8%)

IMPORT GROWTH (June 2023 - June 2024)MYR-26.7M(-14.4%)

MAIN DESTINATION (June 2024)AustraliaMYR1.31M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Malaysia. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download